Su Hui therapy
Driving advancements in vaccine development, cell therapy, and mRNA drug innovation for a healthier future.
Driving advancements in vaccine development, cell therapy, and mRNA drug innovation for a healthier future.
Su Hui therapy
Slogan: Driving advancements in vaccine development, cell therapy, and mRNA drug innovation for a healthier future.
Description: HealiRNA focuses on developing infectious disease vaccines, tumor vaccines, cell therapy, and protein replacement. They specialize in providing mRNA drug research and development, production, clinical trial design, and data analysis services.
Founded: 2021
Industries: Biotechnology
Last Investment: CNY100.00M Seed Round investment at 10 March 2023
Last Investment Investors: Shunwei Capital, Sino-Singapore Capital, Ming Bioventures, Sequoia Capital China, Yajie Shanghui
In summary, Su Hui therapy is a biotechnology startup founded in 2021 that is driving progress in vaccine development, cell therapy, and mRNA drug innovation. The company received a CNY100.00M Seed Round investment on 10 March 2023 from notable investors including Shunwei Capital, Sino-Singapore Capital, Ming Bioventures, Sequoia Capital China, and Yajie Shanghui, positioning it for further growth and advancement in the biotechnology industry.| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Seed Round | CNY100.00M | 5 |
|
10 Mar 2023 |
No recent news or press coverage available for Su Hui therapy.
We care about your data, and we'd love to use cookies make your experience better.
